If the government does not incentivize drugmakers to develop new antibiotics, the World Health Organization (WHO) fears that drug-resistant infections could kill upwards of 10 million people annually by 2050, according to Becker’s Hospital Review.

About 700,000 people die every year due to ineffective antibiotics and most antibiotics that are being developed aren’t targeting the most dangerous, drug-resistant infections. Currently, drugmakers are less inclined to take the initiative to create new antibiotics due to the high costs associated with developing them, and the fact that physicians prefer older, cheaper ones.

According to Sarah Paulin, technical officer of antimicrobial resistance and innovation at the WHO, “We still have a window of opportunity, but we need to ensure there is investment now so we don’t run out of options for future generations.” The New York Times noted that congress is considering a bill that would “support the market for antibiotics but it has not advanced despite bipartisan support”.

COVID-19 cited in significant increase in healthcare-associated infections in 2020

According to ScienceDaily, a CDC analysis of...

Johns Hopkins study shows drones can safely transport large bags of blood

Researchers from Baltimore-based Johns Hopkins...

Researchers show how bending implantable medical devices can lead to bacterial growth

Researchers show how bending implantable medical...

ESTRÉS OXIDATIVO Y OSTEOARTRITIS – SYNOLIS VA

INTRODUCCIÓNEl estrés oxidativo y las ROS...

Widely used hospital gowns show signs of exposing workers to infection

Widely used hospital gowns show signs of...

Webinar: Local Antibiotic Carrier for the Management of Spine Infections

Tema   Webinar: Local Antibiotic Carrier...

6 de enero Día de la Enfermera

Felicidades a todas las enfermeras y enfermeros...